Hims & Hers Health [HIMS] vs Procter & Gamble [PG] Detailed Stock Comparison
Hims & Hers Health
NYSE
Loading...
Procter & Gamble
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Hims & Hers Health wins in 3 metrics, Procter & Gamble wins in 16 metrics, with 0 ties. Procter & Gamble appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Hims & Hers Health | Procter & Gamble | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 65.75 | 23.60 | Procter & Gamble |
| Price-to-Book Ratio | 20.84 | 7.02 | Procter & Gamble |
| Debt-to-Equity Ratio | 185.60 | 69.86 | Procter & Gamble |
| PEG Ratio | 112.91 | 20.71 | Procter & Gamble |
| EV/EBITDA | 71.42 | 15.85 | Procter & Gamble |
| Profit Margin (TTM) | 9.61% | 18.95% | Procter & Gamble |
| Operating Margin (TTM) | 4.91% | 25.15% | Procter & Gamble |
| EBITDA Margin (TTM) | 4.91% | 25.15% | Procter & Gamble |
| Return on Equity | 41.88% | 31.24% | Hims & Hers Health |
| Return on Assets (TTM) | 6.94% | 10.91% | Procter & Gamble |
| Free Cash Flow (TTM) | $198.33M | $14.04B | Procter & Gamble |
| Dividend Yield | N/A | 1.92% | N/A |
| 1-Year Return | 225.44% | -9.99% | Hims & Hers Health |
| Price-to-Sales Ratio (TTM) | 5.83 | 4.27 | Procter & Gamble |
| Enterprise Value | $11.44B | $387.55B | Procter & Gamble |
| EV/Revenue Ratio | 5.68 | 4.60 | Procter & Gamble |
| Gross Profit Margin (TTM) | 76.39% | 49.11% | Hims & Hers Health |
| Revenue per Share (TTM) | $9 | $36 | Procter & Gamble |
| Earnings per Share (Diluted) | $0.79 | $6.51 | Procter & Gamble |
| Beta (Stock Volatility) | 2.09 | 0.37 | Procter & Gamble |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Hims & Hers Health vs Procter & Gamble Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Hims & Hers Health | 1.74% | -16.96% | 6.09% | 1.05% | 16.02% | 106.11% |
| Procter & Gamble | 0.01% | 1.90% | -2.77% | -3.24% | -8.37% | -7.51% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Hims & Hers Health | 225.44% | 626.43% | 383.16% | 430.00% | 430.00% | 430.00% |
| Procter & Gamble | -9.99% | 4.66% | 13.63% | 103.00% | 156.62% | 186.67% |
Performance & Financial Health Analysis: Hims & Hers Health vs Procter & Gamble
| Metric | HIMS | PG |
|---|---|---|
| Market Information | ||
| Market Cap | $11.74B | $359.87B |
| Market Cap Category | Large cap | Mega cap |
| 10 Day Avg. Volume | 40,174,063 | 7,669,488 |
| 90 Day Avg. Volume | 35,468,261 | 8,796,903 |
| Last Close | $51.94 | $153.51 |
| 52 Week Range | $13.47 - $72.98 | $149.91 - $180.43 |
| % from 52W High | -28.83% | -14.92% |
| All-Time High | $72.98 (Feb 17, 2025) | $180.43 (Nov 25, 2024) |
| % from All-Time High | -28.83% | -14.92% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.73% | 0.02% |
| Quarterly Earnings Growth | 2.20% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | 0.19% |
| Operating Margin (TTM) | 0.05% | 0.25% |
| Return on Equity (TTM) | 0.42% | 0.31% |
| Debt to Equity (MRQ) | 185.60 | 69.86 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $2.49 | $21.88 |
| Cash per Share (MRQ) | $5.06 | $4.08 |
| Operating Cash Flow (TTM) | $261.62M | $17.82B |
| Levered Free Cash Flow (TTM) | $93.82M | $11.38B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.92% |
| Last 12-Month Dividend | N/A | $3.03 |
Valuation & Enterprise Metrics Analysis: Hims & Hers Health vs Procter & Gamble
| Metric | HIMS | PG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 65.75 | 23.60 |
| Forward P/E | 112.91 | 20.71 |
| PEG Ratio | 112.91 | 20.71 |
| Price to Sales (TTM) | 5.83 | 4.27 |
| Price to Book (MRQ) | 20.84 | 7.02 |
| Market Capitalization | ||
| Market Capitalization | $11.74B | $359.87B |
| Enterprise Value | $11.44B | $387.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.68 | 4.60 |
| Enterprise to EBITDA | 71.42 | 15.85 |
| Risk & Other Metrics | ||
| Beta | 2.09 | 0.37 |
| Book Value per Share (MRQ) | $2.49 | $21.88 |
Financial Statements Comparison: Hims & Hers Health vs Procter & Gamble
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HIMS | PG |
|---|---|---|
| Revenue/Sales | $586.01M | $20.89B |
| Cost of Goods Sold | $155.32M | $10.63B |
| Gross Profit | $430.69M | $10.26B |
| Research & Development | $29.91M | N/A |
| Operating Income (EBIT) | $57.90M | $4.35B |
| EBITDA | $66.17M | $5.46B |
| Pre-Tax Income | $60.50M | $4.52B |
| Income Tax | $11.01M | $895.00M |
| Net Income (Profit) | $49.49M | $3.63B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HIMS | PG |
|---|---|---|
| Cash & Equivalents | $273.74M | $9.56B |
| Total Current Assets | $446.96M | $25.39B |
| Total Current Liabilities | $280.36M | $36.06B |
| Long-Term Debt | $59.65M | $25.70B |
| Total Shareholders Equity | $549.26M | $52.28B |
| Retained Earnings | $-192.65M | $129.97B |
| Property, Plant & Equipment | $129.84M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HIMS | PG |
|---|---|---|
| Operating Cash Flow | $122.67M | $3.71B |
| Capital Expenditures | $-55.33M | N/A |
| Free Cash Flow | $50.05M | $2.85B |
| Debt Repayment | N/A | $-1.05B |
| Common Stock Repurchase | $0 | $-1.35B |
Short Interest & Institutional Ownership Analysis
| Metric | HIMS | PG |
|---|---|---|
| Shares Short | 65.30M | 14.72M |
| Short Ratio | 1.42 | 1.51 |
| Short % of Float | 0.36% | 0.01% |
| Average Daily Volume (10 Day) | 40,174,063 | 7,669,488 |
| Average Daily Volume (90 Day) | 35,468,261 | 8,796,903 |
| Shares Outstanding | 220.84M | 2.34B |
| Float Shares | 196.79M | 2.34B |
| % Held by Insiders | 0.11% | 0.00% |
| % Held by Institutions | 0.81% | 0.70% |
Dividend Analysis & Yield Comparison: Hims & Hers Health vs Procter & Gamble
| Metric | HIMS | PG |
|---|---|---|
| Last 12-Month Dividend | N/A | $3.03 |
| Last 12-Month Dividend Yield | N/A | 1.92% |
| 3-Year Avg Annual Dividend | N/A | $3.51 |
| 3-Year Avg Dividend Yield | N/A | 0.63% |
| 3-Year Total Dividends | N/A | $10.53 |
| Ex-Dividend Date | N/A | Jan 24, 2025 |